Hana Plesingerova
Overview
Explore the profile of Hana Plesingerova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vyhlidalova Kotrbova A, Gomoryova K, Mikulova A, Plesingerova H, Sladecek S, Kravec M, et al.
J Extracell Vesicles
. 2024 Mar;
13(3):e12420.
PMID: 38490958
High-grade serous carcinoma of the ovary, fallopian tube and peritoneum (HGSC), the most common type of ovarian cancer, ranks among the deadliest malignancies. Many HGSC patients have excess fluid in...
2.
cada S, Vondalova Blanarova O, Gomoryova K, Mikulova A, Bacovska P, Zezula N, et al.
Front Cell Dev Biol
. 2022 Dec;
10:911966.
PMID: 36561363
The migratory properties of leukemic cells are commonly associated with their pathological potential and can significantly affect the disease progression. While the research in immunopathology mostly employed powerful indirect methods...
3.
Plesingerova H, Janovska P, Mishra A, Smyckova L, Poppova L, Libra A, et al.
Haematologica
. 2017 Nov;
103(2):313-324.
PMID: 29122990
Chronic lymphocytic leukemia is a disease with up-regulated expression of the transmembrane tyrosine-protein kinase ROR1, a member of the Wnt/planar cell polarity pathway. In this study, we identified COBLL1 as...
4.
Poppova L, Janovska P, Plevova K, Radova L, Plesingerova H, Borsky M, et al.
Br J Haematol
. 2016 Sep;
175(5):851-859.
PMID: 27651098
The canonical Wnt pathway, dependent on β-catenin-controlled transcription, is the most explored Wnt pathway, known to drive the malignant transformation of multiple cell types. Several reports have suggested that this...
5.
Plesingerova H, Librova Z, Plevova K, Libra A, Tichy B, Skuhrova Francova H, et al.
Leuk Lymphoma
. 2016 May;
58(1):70-79.
PMID: 27185377
The clinical course of chronic lymphocytic leukemia (CLL) is highly variable. Patients with unmutated IGHV (U-CLL) usually progress rapidly, whereas patients with mutated IGHV (M-CLL) have a more indolent disease....
6.
Janovska P, Poppova L, Plevova K, Plesingerova H, Behal M, Kaucka M, et al.
Clin Cancer Res
. 2015 Aug;
22(2):459-69.
PMID: 26240275
Purpose: ROR1, a receptor in the noncanonical Wnt/planar cell polarity (PCP) pathway, is upregulated in malignant B cells of chronic lymphocytic leukemia (CLL) patients. It has been shown that the...